explore -WSS

explore

author：hotspot 2025-10-02 21:05:41 - browse：2

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Carbon Health diabetes program, a test of data

hotspot

WSS

Ohio still needs to do more to protect the right to abortion

The system is set up to fail children with medical complexity

Readers discuss the intersection of pregnancy and addiction

White House drug czar issues call for 'recovery

Health care court cases: Humana, Sutter, Novant

Cancer diagnosis changes perspective doctor, former hospital CEO

hotspot

explore

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Drug repurposing or repositioning? The language matters

NIH tests clinical research in primary care with $30 million program

How one medical school became remarkably diverse

Teladoc has a new CEO, but challenges remain the same

Bright Health sells Medicare Advantage business to Molina

Today's health inequities arise from racist U.S. history, say experts

Supreme Court strikes down use of affirmative action

ALS patient reclaims some autonomy thanks to wearable 'robot'

focus

Cheap, fast test for Zika and dengue could cost just $1

Ohio still needs to do more to protect the right to abortion

Study suggests Covid rebound is far more common with Paxlovid than without

5 takeaways from STAT's examination of Zynex Medical

How state and local governments are sidelining science

Deposition: Sackler embraced plan to conceal OxyContin’s strength

hotspot

focus

hotspot

Wikipedia